-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIGHT MINDS TO ANNOUNCE TOPLINE RESULTS FOR BMB-101 PHASE 2 TRIAL IN ABSENCE SEIZURES AND DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES ON TUESDAY, JANUARY 6, 2026

Reuters·01/05/2026 21:30:00

Please log in to view news